Open original FDA record ↗Recall record
- FDA identifier
- Z-0470-2022
- Company in FDA record
- Reflexion Medical, Inc.
- FDA record creation date
- Jan 10, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Due to dose discrepancy when delivering a plan to a patient in a Non-HFS (Head First Supine) orientation specifically in Feet First Supine (FFS).
Source facts
- Action
- On 11/24/2021 and 12/02/2021, the firm emailed customers to inform them of an ongoing investigation a potential dose discrepancy while treating patients in an orientation other than Head First Supine (HFS), i.e., Feet First Supine (FFS) and Head First Prone (HFP) and Feet First Prone (FFP). On 12/22/2021, the firm sent an "Urgent Safety Notification" letter to customers informing them that the Recalling Firm has confirmed that a dose discrepancy exists for patients treated in any orientation other than Head First Supine (HFS). Customers are instructed, until the updated software is install at their institution, the Recalling Firm recommends using only the HFS orientation when treating patients on the affected systems. It is estimated that a software updated to address the issue will be installed at all sites by mid to late January 2022. For questions, contact the Senior Director of Technical Support at 650-263-8888 or email support@reflexion.com
- Initiated
- 2021-11-24
- Root cause
- Software design
- Terminated
- 2024-07-08
- Distribution
- U.S. Nationwide distribution in the states of CA and TX
- Recall number
- Z-0470-2022
- Recall status
- Terminated
- CDRH record ID
- 190799
- FDA record created
- 2022-01-10
- Recall event number
- 89212